TABLE 1.
Clinical characteristics of newly diagnosed patients
| Characteristics | Median (range) | All cases |
|---|---|---|
| Sex | ||
| Female | 50 | |
| Male | 31 | |
| Total | 81 | |
| Median age, y | 53.3 (26–77) | |
| Younger than 40 y | 19 | |
| 40–60 y | 35 | |
| Older than 60 y | 27 | |
| Median WBC, 109/L | 61.8 (0.5–285) | |
| Median platelets, 109/L | 122.4 (23–602) | |
| iron deficiency anemia | 27 | |
| AML | 54 | |
| AML FAB subtype | ||
| AML without maturation:M1 | 6 | |
| AML with maturation:M2 | 8 | |
| Acute promyelocytic leukaemia:M3 | 8 | |
| Acute myelomonocytic leukaemia:M4 | 17 | |
| Acute monoblastic or monocytic leukaemia:M5 | 15 | |
| unclassified | 0 | |
| Karyotype | ||
| Normal | 27 | |
| t (8;21) | 7 | |
| t (15;17) | 6 | |
| inv (16) | 14 | |
| Unknown | 0 | |
| Gene mutations | ||
| NPM1 | 27 | |
| FLT3/ITD | 14 | |
| WT1 | 8 | |
| DNMT3A | 12 |
Abbreviations: AML, acute myeloid leukaemia; FAB classification, French‐American‐British classification, a classification of acute leukaemia produced by three‐nation joint collaboration.; WBC, white blood cell; y, year old.